Susquehanna International Group
OM icon

Susquehanna International Group’s Outset Medical OM Stock Holding History

Susquehanna International Group’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.2K Buy
+12,800
New +$52.5K ﹤0.01% 12639
2025
Q3 		– Sell
-19,200
Closed -$369K – 13472
2025
Q2 		$369K Sell
19,200
-65,900
-77% -$1.03M ﹤0.01% 9877
2025
Q1 		$941K Buy
85,100
+82,767
+3,548% +$987K ﹤0.01% 7406
2024
Q4 		$38.9K Buy
2,333
+960
+70% +$12K ﹤0.01% 11771
2024
Q3 		$14K Buy
+1,373
New +$40.8K ﹤0.01% 11685
2024
Q1 		– Sell
-2,020
Closed -$164K – 12997
2023
Q4 		$164K Buy
+2,020
New +$164K ﹤0.01% 10886
2022
Q4 		– Sell
-907
Closed -$217K – 13311
2022
Q3 		$217K Sell
907
-373
-29% -$99.9K ﹤0.01% 10626
2022
Q2 		$285K Sell
1,280
-640
-33% -$275K ﹤0.01% 9705
2022
Q1 		$1.31M Sell
1,920
-567
-23% -$341K ﹤0.01% 6467
2021
Q4 		$1.72M Buy
2,487
+1,020
+70% +$754K ﹤0.01% 5867
2021
Q3 		$1.09M Buy
+1,467
New +$1,000K ﹤0.01% 7333

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Susquehanna International Group's OM Position: Q1 2026 in Review

Susquehanna International Group increased its Outset Medical (OM) stake by 13% in Q1 2026, buying an estimated $13K and bringing the position to 27,880 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #12296.

Susquehanna International Group first reported a position in OM in Q3 2020 and has held it in 17 quarters since. The position peaked at $1.36M in Q2 2023. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • Susquehanna International Group held 27,880 shares of Outset Medical worth $107K as of Q1 2026.
  • Susquehanna International Group bought 3,166 Outset Medical shares in Q1 2026, an estimated $13K.
  • Outset Medical made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12296 holding.
  • Susquehanna International Group first reported a position in Outset Medical in Q3 2020 and has held it in 17 quarters since.
  • Susquehanna International Group's Outset Medical position peaked at $1.36M in Q2 2023.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.